Effect of radioprotectors on damage induced by alkylating agents on tumoural and normal tissues

S. Garattini, V. Palma, I. R D Innocenti, A. Guaitani

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A quantitative investigation was carried out to establish the usefulness of radioprotector drugs in combination with alkylating agents for the chemotherapy of Ehrlich carcinoma and Sarcoma 180 in mice. Tumoural growth, spleen weight and number of blood white cells were measured. The results show that a protection against the damage induced by alkylating agents on spleen and white cells was always achieved at doses of radioprotectors able to prevent also the antitumoural activity of the same alkylating agent. Despite the large range of doses and schedule of treatment tried it was impossible to produce evidence that the combination radioprotectors + alkylating agents was useful.

Original languageEnglish
Pages (from-to)237-244
Number of pages8
JournalEuropean Journal of Cancer (1965)
Volume2
Issue number3
Publication statusPublished - Aug 1966

Fingerprint

Alkylating Agents
Spleen
Sarcoma 180
Drug Combinations
Appointments and Schedules
Leukocytes
Carcinoma
Weights and Measures
Drug Therapy
Growth
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of radioprotectors on damage induced by alkylating agents on tumoural and normal tissues. / Garattini, S.; Palma, V.; Innocenti, I. R D; Guaitani, A.

In: European Journal of Cancer (1965), Vol. 2, No. 3, 08.1966, p. 237-244.

Research output: Contribution to journalArticle

@article{ed3ce5219b0e484cb658ad758b285ed6,
title = "Effect of radioprotectors on damage induced by alkylating agents on tumoural and normal tissues",
abstract = "A quantitative investigation was carried out to establish the usefulness of radioprotector drugs in combination with alkylating agents for the chemotherapy of Ehrlich carcinoma and Sarcoma 180 in mice. Tumoural growth, spleen weight and number of blood white cells were measured. The results show that a protection against the damage induced by alkylating agents on spleen and white cells was always achieved at doses of radioprotectors able to prevent also the antitumoural activity of the same alkylating agent. Despite the large range of doses and schedule of treatment tried it was impossible to produce evidence that the combination radioprotectors + alkylating agents was useful.",
author = "S. Garattini and V. Palma and Innocenti, {I. R D} and A. Guaitani",
year = "1966",
month = "8",
language = "English",
volume = "2",
pages = "237--244",
journal = "European Journal of Cancer",
issn = "0014-2964",
publisher = "Elsevier Ltd",
number = "3",

}

TY - JOUR

T1 - Effect of radioprotectors on damage induced by alkylating agents on tumoural and normal tissues

AU - Garattini, S.

AU - Palma, V.

AU - Innocenti, I. R D

AU - Guaitani, A.

PY - 1966/8

Y1 - 1966/8

N2 - A quantitative investigation was carried out to establish the usefulness of radioprotector drugs in combination with alkylating agents for the chemotherapy of Ehrlich carcinoma and Sarcoma 180 in mice. Tumoural growth, spleen weight and number of blood white cells were measured. The results show that a protection against the damage induced by alkylating agents on spleen and white cells was always achieved at doses of radioprotectors able to prevent also the antitumoural activity of the same alkylating agent. Despite the large range of doses and schedule of treatment tried it was impossible to produce evidence that the combination radioprotectors + alkylating agents was useful.

AB - A quantitative investigation was carried out to establish the usefulness of radioprotector drugs in combination with alkylating agents for the chemotherapy of Ehrlich carcinoma and Sarcoma 180 in mice. Tumoural growth, spleen weight and number of blood white cells were measured. The results show that a protection against the damage induced by alkylating agents on spleen and white cells was always achieved at doses of radioprotectors able to prevent also the antitumoural activity of the same alkylating agent. Despite the large range of doses and schedule of treatment tried it was impossible to produce evidence that the combination radioprotectors + alkylating agents was useful.

UR - http://www.scopus.com/inward/record.url?scp=0013936185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0013936185&partnerID=8YFLogxK

M3 - Article

C2 - 5974760

AN - SCOPUS:0013936185

VL - 2

SP - 237

EP - 244

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0014-2964

IS - 3

ER -